Charlene Banard, Former Global Head of Technical Operations Cell & Gene Therapy Strategy, Innovation Pipeline and PMONovartis
Jeffrey Berkowitz, Board MemberH. Lundbeck A/S
Ron Cohen, M.D., President & CEOAcorda Therapeutics
Pamela Reilly Contag, Ph.D., Cofounder and CEOBioEclipse Therapeutics
Lisa Conte, founder, president, and CEOJaguar Health
John Crowley, Executive ChairmanAmicus Therapeutics
Rich Daly, PresidentCARsgen Therapeutics
Raúl Díaz, Senior PartnerBunka, Inc
Tom Dilenge, Senior Partner for Global Public Policy, Regulatory and Governmental StrategyFlagship Pioneering
Joseph Ferra, CFOElevation Oncology
Anu Hans, VP, Strategic InitiativesJanssen Supply Chain
Fred Hassan, Managing DirectorWarburg Pincus
Paul Hastings, President and CEONkarta Therapeutics
Axel Hoos, M.D., Ph.D., CEOScorpion Therapeutics
John Hubbard, Ph.D., Emeritus Editorial Advisory Board MemberLife Science Leader
Mitchell Katz, Ph.D., VSVP, Global Clinical OperationsKyowa Kirin
Mary Rose Keller, VP, Head Of Clinical OperationsAcrivon Therapeutics
Jacks Lee, SVP Global Manufacturing and SupplyMerck
Martin Lehr, CEOContext Therapeutics
Sandy Macrae, Ph.D., President & CEOSangamo Therapeutics
Ken Moch, PresidentEuclidean Life Science Advisors, LLC
Sandra E. Poole, Chief Operating OfficerMythic Therapeutics
Dennis Purcell, Founder & Sr. AdvisorAisling Capital
David Pyott, Board MemberAlnylam Pharmaceuticals
Paula Ragan, Cofounder, President and CEOX4 Pharmaceuticals
Chandra Ramanathan, Global Head of Innovation HubsDanaher Corporation
Stephen Rapundalo, Ph.D., President & CEOMichBio
John Reynders, Ph.D., VP, R&D Strategy, Program Management, and Data SciencesAlexion
James Robinson, Emeritus Editorial Advisory Board MemberLife Science Leader
Tomasz Sablinski, M.D., Ph.D., Managing Director, Head of Clinical DevelopmentAuven Therapeutics
Jim Scibetta, CEOImmuneID
Chhaya Shah, SVP Technical OperationsRadius Health
Allan Shaw, Independent Consultant
Brandi Simpson, VP Business and Corporate DevelopmentVoyager Therapeutics
Andrew Skibo, Emeritus Editorial Advisory Board Member, Life Science LeaderMedImmune / AstraZeneca
Jason Urban, Ph.D., Sr. Dir. Quality Risk ManagementAlexion
Thomas Wiggans, Founder, CEO, ChairmanDermira
Leslie Williams, Cofounder, President and CEO hC Bioscience, Inc.
Tim Wright, CEOMiMedx
ASK THE BOARD
- In September, You Testified Before Congress On The Inflation Reduction Act's (IRA) Real-World Impact On Rare Disease R&D And Small Molecule Therapies. Can You Summarize The Key Points?
- What New Technologies Offer The Most Promise For Improving Global Supply Chain Operations?
- Given Drug Development Time Horizons, How Does A Company Best Navigate The Inevitable Vagaries Of Investor Therapeutic/Modality Sentiment And Its Collateral Consequences On Funding?
- How Can Leaders Balance Requests Of Employees To Continue Remote Working With The Need For Increased Business Efficiency And Achieving Strong Dynamics Among A Management Team?
- What Impact Is The Inflation Reduction Act Already Having On Biopharma Companies, And What More Can The Industry Do Going Forward?
- How Can Executives Work Through Tightened Budgets And Manage Tradeoffs While Keeping The Workforce Happy And Motivated?
IN THIS MONTH'S ISSUE
- Gene Editing Versus Gene Therapy: Is There A Difference?
- The Ozempic Dilemma: What Makes A Dual Brand Approach Viable?
- Ensuring Diversity And Accessibility In Neurological Research
- A New Year's Resolution Suggestion For The FDA
- Pharma's Customer Engagement Evolution: Is Your Data Governance Keeping Pace?